Skip to main content
SpringerLink
Log in
Book cover

Understanding Suicide pp 403–413Cite as

A Need for Personalised Suicidology: Pharmacoepidemiology

  • Chapter
  • First Online:

  • 2233 Accesses

Abstract

A principal issue in pharmacoepidemiology is to estimate the impact of drugs on suicide risk in view of numerous methodological limitations. Owing to methodological concerns or differences, the findings of studies are often conflicting so it is difficult to draw conclusions about the suicide risk associated with drugs. An additional challenge in personalised suicidology is to identify characteristics of patients whose risk of suicide is increased when they are exposed to specific drugs. In this review, we investigate the impact of drugs on suicide risk in specific populations and the characteristics associated with an increased risk for the various therapeutic classes on the basis of the available data. Suicidal behaviours are linked to at least 58 different approved prescription drugs. The main mentioned classes are antidepressants, anticonvulsants and smoking cessation drugs. Antidepressants, anticonvulsants and sedative medications have been associated with suicidal behaviour in specific contexts. However, these associations remain to be proven and their mechanisms elucidated.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ahearn EP, Chen P, Hertzberg M et al (2013) Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. J Affect Disord 145:77–82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM (2010) Suicide-related events in patients treated with antiepileptic drugs. NEJM 363:542–551

    Article  CAS  PubMed  Google Scholar 

  • Ayuso-Mateos JL, Baca-Garcia E, Bobes J et al (2012) Recommendations for the prevention and management of suicidal behaviour. Rev Psiquiatr Salud Ment 5:8–23

    Article  PubMed  Google Scholar 

  • Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L et al (2009) Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 166:418–426

    Article  PubMed  PubMed Central  Google Scholar 

  • Carlsten A, Waern M (2009) Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr 9:20

    Article  PubMed  PubMed Central  Google Scholar 

  • Carvalho AF, Dimellis D, Gonda X, Vieta E, McLntyre RS, Fountoulakis KN (2014) Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry 75:e578–e586

    Article  PubMed  Google Scholar 

  • Chen Q, Sjolander A, Runeson B, D’Onofrio BM, Lichtenstein P, Larsson H (2014) Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study. BMJ 348:g3769

    Article  PubMed  PubMed Central  Google Scholar 

  • Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E (2007) Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 6:693–698

    Article  PubMed  Google Scholar 

  • Cooper WO, Callahan ST, Shintani A et al (2014) Antidepressants and suicide attempts in children. Pediatrics 133:204–210

    Article  PubMed  PubMed Central  Google Scholar 

  • Darke S, Ross J, Lynskey M, Teesson M (2004) Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors. Drug Alcohol Depend 73:1–10

    Article  PubMed  Google Scholar 

  • Gibbons RD, Mann JJ (2011) Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned? Drug Saf 34:375–395

    Article  PubMed  Google Scholar 

  • Gibbons RD, Mann JJ (2013) Varenicline, smoking cessation, and neuropsychiatric adverse events. Am J Psychiatry 170:1460–1467

    Article  PubMed  PubMed Central  Google Scholar 

  • Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ (2012) Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:580–587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gibbons RD, Coca Perraillon M, Hur K, Conti RM, Valuck RJ, Brent DA (2015) Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidemiol Drug Saf 24:208–214

    Google Scholar 

  • Hawton K, Casanas ICC, Haw C, Saunders K (2013) Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord 147:17–28

    Article  PubMed  Google Scholar 

  • Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN (2012) Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev 11:CD004851

    PubMed  Google Scholar 

  • Isacsson G, Rich CL (2014) Antidepressant drugs and the risk of suicide in children and adolescents. Pediatr Drugs 16:115–122

    Article  Google Scholar 

  • Leon AC, Demirtas H, Li C, Hedeker D (2012) Two propensity score-based strategies for a three-decade observational study: investigating psychotropic medications and suicide risk. Stat Med 31:3255–3260

    Article  PubMed  Google Scholar 

  • Maloney E, Degenhardt L, Darke S, Mattick RP, Nelson E (2007) Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study. Addiction 102:1933–1941

    Article  PubMed  Google Scholar 

  • Miller M, Pate V, Swanson SA et al (2014a) Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA. CNS Drugs 28:79–88

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miller M, Swanson SA, Azrael D, Pate V, Sturmer T (2014b) Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Intern Med 174:899–909

    Article  CAS  PubMed  Google Scholar 

  • Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S (2011) Suicidal behavior and depression in smoking cessation treatments. PLoS One 6:e27016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mula M, Sander JW (2013) Suicide risk in people with epilepsy taking antiepileptic drugs. Bipolar Disord 15:622–627

    Article  PubMed  Google Scholar 

  • Mula M, Kanner AM, Schmitz B, Schachter S (2013) Antiepileptic drugs and suicidality: an expert consensus statement from the task force on therapeutic strategies of the ILAE commission on neuropsychobiology. Epilepsia 54:199–203

    Article  CAS  PubMed  Google Scholar 

  • Pugh MJ, Copeland LA, Zeber JE et al (2012) Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J Am Geriatr Soc 60:2042–2047

    PubMed  Google Scholar 

  • Pugh MJ, Hesdorffer D, Wang CP, Amuan ME, Tabares JV, Finley EP et al (2013) Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior. Neurology 81:1900–1906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raja M, Azzoni A, Koukopoulos AE (2009) Psychopharmacological treatment before suicide attempt among patients admitted to a psychiatric intensive care unit. J Affect Disord 113:37–44

    Article  PubMed  Google Scholar 

  • Rihmer Z, Gonda X (2013) Pharmacological prevention of suicide in patients with major mood disorders. Neurosci Biobehav Rev 37:2398–2403

    Article  PubMed  Google Scholar 

  • Ringback Weitoft G, Berglund M, Lindstrom EA, Nilsson M, Salmi P, Rosen M (2014) Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study. Pharmacoepidemiol Drug Saf 23:290–298

    Article  PubMed  Google Scholar 

  • Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A et al (2009) Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339:b2880

    Article  PubMed  PubMed Central  Google Scholar 

  • Thomas KH, Martin RM, Davies NM, Metcalfe C, Windmeijer F, Gunnell D (2013) Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study. BMJ 347:f5704

    Article  PubMed  PubMed Central  Google Scholar 

  • Thomas KH, Martin RM, Potokar J, Pirmohamed M, Gunnell D (2014) Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011. BMC Pharmacol Toxicol 15:54

    Article  PubMed  PubMed Central  Google Scholar 

  • Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P (2012) Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 69:476–483

    Article  CAS  PubMed  Google Scholar 

  • Valenstein M, Kim HM, Ganoczy D et al (2009) Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. J Affect Disord 112:50–58

    Article  PubMed  PubMed Central  Google Scholar 

  • VanCott AC, Cramer JA, Copeland LA, Zeber JE, Steinman MA, Dersh JJ et al (2010) Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 8:4

    Article  PubMed  PubMed Central  Google Scholar 

  • Wasserman D, Rihmer Z, Rujescu D et al (2012) The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry 27:129–141

    Article  CAS  PubMed  Google Scholar 

  • Wines JD Jr, Saitz R, Horton NJ, Lloyd-Travaglini C, Samet JH (2004) Suicidal behavior, drug use and depressive symptoms after detoxification: a 2-year prospective study. Drug Alcohol Depend 76:S21–S29

    Article  PubMed  Google Scholar 

  • Yerevanian BI, Choi YM (2013) Impact of psychotropic drugs on suicide and suicidal behaviors. Bipolar Disord 15:594–621

    Article  PubMed  Google Scholar 

  • Youssef NA, Rich CL (2008) Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Ann Clin Psychiatry 20:157–169

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. INSERM U657, F-33000, Bordeaux, France

    Marie Tournier

  2. Univ. de Bordeaux, U657, F-33000, Bordeaux, France

    Marie Tournier

  3. Centre Hospitalier Charles Perrens, 121 rue de la Béchade, 33076, Bordeaux cedex, France

    Marie Tournier

Authors
  1. Marie Tournier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marie Tournier .

Editor information

Editors and Affiliations

  1. Academic Hospital of Montpellier, University of Montpellier, Montpellier, France

    Philippe Courtet

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Tournier, M. (2016). A Need for Personalised Suicidology: Pharmacoepidemiology. In: Courtet, P. (eds) Understanding Suicide. Springer, Cham. https://doi.org/10.1007/978-3-319-26282-6_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26282-6_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26280-2

  • Online ISBN: 978-3-319-26282-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation